MKI67 and breast carcinoma: Breast cancer is a highly heterogeneous disease, with different breast cancer cell types, characterized by the expression of estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2), and the proliferation marker Ki67, all exhibiting marked differences in sensitivity to ferroptosis.